Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block

Anesthesiology

Volumn 113, Issue 5, 2010, Pages 1054-1060

  Schaller, Stefan J ^a   Fink, Heidrun ^a   Ulm, Kurt ^b   Blobner, Manfred ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NEOSTIGMINE; PLACEBO; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; TACHYCARDIA; ULNAR NERVE PARALYSIS; ANESTHETIC RECOVERY; COMPARATIVE STUDY; MIDDLE AGED; PATIENT MONITORING; PROCEDURES;

ADULT; ANESTHESIA RECOVERY PERIOD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE;

EID: 78049345252     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181f4182a     Document Type: Article

References (21)

1. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS: Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-7
2. Eikermann M, Blobner M, Groeben H, Rex C, Grote T, Neuhäuser M, Beiderlinden M, Peters J: Postoperative up-per airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade. Anesth Analg 2006; 102:937-42
3. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuro-nium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-103
4. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heer-inga M, Klimek M: Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: A multicenter, dose-finding and safety study. ANESTHESIOLOGY 2007; 107:239-44
5. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM: Early reversal of profound rocuronium-induced neuromuscular blockade by sugam-madex in a randomized multicenter study: Efficacy, safety, and pharmacokinetics. ANESTHESIOLOGY 2007; 106:935-43
6. Groudine SB, Soto R, Lien C, Drover D, Roberts K: A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104:555-62
7. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Oster-gaard D, Prins ME, Viby-Mogensen J: Reversal of rocuro-nium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. ANESTHESIOLOGY 2006; 104:667-74
8. Debaene B, Plaud B, Dilly MP, Donati F: Residual paralysis in the PACU after a single intubating dose of nondepolar-izing muscle relaxant with an intermediate duration of action. ANESTHESIOLOGY 2003; 98:1042-8
9. Maybauer DM, Geldner G, Blobner M, Pühringer F, Hof-mockel R, Rex C, Wulf HF, Eberhart L, Arndt C, Eikermann M: Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia 2007; 62:12-7
10. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC: Postoperative residual block after intermediate-acting neu-romuscular blocking drugs. Anaesthesia 2001; 56:312-8
11. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J, 8th International Neuro-muscular Meeting: Good clinical research practice in phar-macodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808
12. Medical Research Council. Aids to the examination of the peripheral nervous system, memorandum no. 45. London: Her Majesty's Stationary Office, 1976
13. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS: Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by su-gammadex at two different time points: An international, mul-ticenter, randomized, dose-finding, safety assessor-blinded, phase II trial. ANESTHESIOLOGY 2008; 109:188-97
14. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ: A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cy-clodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41:266-70
15. Robertson EN, Driessen JJ, Booij LH: Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesthesiol 2005; 22:4-10
16. Paton WD, Waud DR: The margin of safety of neuromus-cular transmission. J Physiol (Lond) 1967; 191:59-90
17. Bartkowski RR: Incomplete reversal of pancuronium neu-romuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg 1987; 66:594-8
18. Calvey TN, Wareing M, Williams NE, Chan K: Pharmaco-kinetics and pharmacological effects of neostigmine in man. Br J Clin Pharmacol 1979; 7:149-55
19. Kim KS, Cheong MA, Lee HJ, Lee JM: Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia. Anesth Analg 2004; 99:1080-5
20. Reid JE, Breslin DS, Mirakhur RK, Hayes AH: Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anaesth 2001; 48:351-5
21. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuth-rich Y, Donati F: Antagonism of low degrees of atracurium-induced neuromuscular blockade: Dose-effect relationship for neostigmine. ANESTHESIOLOGY 2010; 112:34-40